BPGbio, Inc. Email Format
Biotechnology ResearchMassachusetts, United States51-200 Employees
BPGbio, Inc. is a mid-sized biotechnology company based in Waltham, Massachusetts, in the greater Boston area. It operates as a clinical-stage biopharma that uses AI-driven biology to study mitochondrial function and protein homeostasis. Its pipeline spans oncology, rare diseases and neurology, with several candidates in late-stage clinical development. The company’s capabilities are supported by its NAi Interrogative Biology Platform, a broad patent portfolio, access to a large clinically annotated biobank, and exclusive access to a powerful supercomputer. In June 2026, Eric J. Nestler was appointed Chair of the Scientific Advisory Board, with Chas Bountra transitioning to Executive Vice President and Chief Scientific Officer.